Drug self-delivery nanorods enhance photodynamic therapy of triple-negative breast cancer by inhibiting oxidative phosphorylation-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Drug self-delivery nanorods enhance photodynamic therapy of triple-negative breast cancer by inhibiting oxidative phosphorylation

Published:2022-06 Issue: Volume:621 Page:121775
ISSN:0378-5173
Container-title:International Journal of Pharmaceutics
language:en
Short-container-title:International Journal of Pharmaceutics

Author:

Gao Wenhao,Zhang Jialiang,Wang Weifeng,Liu Zhihong,Chen Mulan,Hu Xiaomu,Zeng Lingjun,Zheng Changqing,Song Hongtao,Zhang Qian

Funder

Fujian Provincial Health Commission

Fujian Provincial Health Technology Project

Natural Science Foundation of Fujian Province

Fujian Medical University

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference44 articles.

1. Anti-angiogenic treatment in breast cancer: facts, successes, failures and future perspectives;Aalders;Can. Treat. Rev.,2017

2. Antitumor effects of everolimus and metformin are complementary and glucose-dependent in breast cancer cells;Ariaans;BMC Can.,2017

3. Photodynamic therapy in primary breast cancer;Banerjee;J. Clin. Med.,2020

4. DLS and zeta potential – what they are and what they are not?;Bhattacharjee;J. Control. Release,2016

5. Triple-negative breast cancer: disease entity or title of convenience? Nature reviews;Carey;Clin. Oncol.,2010

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Self-Delivery Nanobooster to Enhance Immunogenic Cell Death for Cancer Chemoimmunotherapy;ACS Applied Materials & Interfaces;2024-06-25

2. Oestrogen receptor positive breast cancer and its embedded mechanism: breast cancer resistance to conventional drugs and related therapies, a review;Open Biology;2024-06

3. Co-delivery of Paclitaxel/Atovaquone/Quercetin to regulate energy metabolism to reverse multidrug resistance in ovarian cancer by PLGA-PEG nanoparticles;International Journal of Pharmaceutics;2024-04

4. Self-Delivery Nanomedicines Reverse Thermal Resistance to Enhance Tumor Mild-Temperature Photothermal Therapy;Molecular Pharmaceutics;2024-02-21

5. Construction and Validation of an Oxidative Phosphorylation Signature in High‐Grade Glioma and Potential Inhibitors Screening;Analytical Cellular Pathology;2024-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3